Are eicosapentaenoic acid and docosapentaenoic acid monoglycerides more potent than docosahexaenoic acid monoglyceride to resolve inflammation in a rheumatoid arthritis model?
Altogether, the present data suggest that MAG-EPA, without vitamin E, represents a new potential therapeutic strategy for resolving inflammation in arthritis.
Because COL6A1 could be a susceptibility to the occurrence of DISH and OPLL in the Japanese population, we consider that COL6A1 could be responsible for the hyperostotic state, leading to ectopic bone formation in the spinal ligament.